Cryogenetics AS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cryogenetics AS - overview
Established
2002
Location
-, -, Norway
Primary Industry
Software
About
Based in Norway, Cryogenetics AS specializes in advanced cryopreservation and fertilization technologies for the aquaculture industry, providing innovative solutions to enhance hatchery productivity and support conservation efforts. Cryogenetics AS, founded in 2002 in Norway, focuses on providing cryopreservation solutions primarily for the aquaculture sector. In October 2024, Bluefront Equity acquired an 80% majority stake in the company from its previous investors, intending to support its growth strategy. The company has completed 2 deals to date.
Cryogenetics AS specializes in advanced cryopreservation and fertilization technologies aimed primarily at the aquaculture industry, research institutions, and conservation efforts. The company offers a comprehensive range of products and services designed to enhance fish hatchery output, which includes their proprietary QuattroMachine for efficient milt extraction and handling, as well as high-capacity thawing equipment for industrial-scale fertilization operations. Additional offerings include consulting services, reproduction-enhancing remedies such as AquaBoost®, and optimized processes for egg production. Their services extend globally, with capabilities for both laboratory-based cryopreservation and on-site operations, ensuring accessibility for clients across various geographical markets, including Europe, North America, and Asia.
In 2016, Cryogenetics AS reported a revenue of USD 1,841,724. 20 and an EBITDA of USD -329,856. 40, generating income through direct sales of equipment, consulting services, and partnerships with clients in the aquaculture sector. Following the acquisition on October 21, 2024, Cryogenetics AS plans to leverage its new investment to support the next phase of growth and expansion both in Norway and internationally.
The company aims to introduce new products and enhance its service offerings, with specific plans targeting new markets in Europe, North America, and Asia by 2025. The recent investment will facilitate the development of new technologies and expand existing operations to meet rising demand in the aquaculture industry.
Current Investors
Investinor
Primary Industry
Software
Sub Industries
Consulting Services, Industrial Machinery, Fishing & Seafood
Website
www.cryogenetics.com
Verticals
Research (Non-Medical)
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.